Launch clarifies how science, healthcare, philanthropy, advisory services, and investment work together under one enterprise vision. [Boston, MA] — Melhem Holdings today announced the launch of a new enterprise brand and a coordinated identity system for Melhem Holdings and its portfolio entities: Melhem Scientific, Melhem Pharmaceuticals, Melhem Foundation, Melhem Consultancy, and Melhem Investments. The initiative is designed to make a complex ecosystem feel clear, intentional, and...

New Shanghai-Based Enterprise to Accelerate Global Healthcare Innovation, Artificial Intelligence, Biotechnology, Digital Health, and Medical Technology Commercialization WASHINGTON, D.C. — Melhem Medical Technologies, Inc. (MMT), a United States-based healthcare innovation company, and Shanghai Xinhao International Trade Co., Ltd. (Xinhao), a leading China-based international trade and business development enterprise, today announced the signing of a strategic Joint Venture Memorandum of...

Memorandum of Understanding aligns research, pharmaceutical execution, and global access initiatives Discovery to delivery—powered by science, strengthened by global access. WASHINGTON, D.C., April 30, 2026 — Melhem Scientific and Melhem Pharmaceuticals today announced the formal signing of a Memorandum of Understanding (MOU), establishing a unified strategic framework to accelerate collaboration across research, pharmaceutical access, and healthcare innovation. The agreement executed Feb....